Theranostic nanoparticles based on magnetic nanoparticles: design, preparation, characterization, and evaluation as novel anticancer drug carrier and MRI contrast agent

Drug Development and Industrial Pharmacy
Hamed NosratiHossein Danafar

Abstract

In this work, we reported the synthesis of curcumin (CUR)-loaded hydrophilic and hydrophobic natural amino acids (AAs)-modified iron oxide magnetic nanoparticles (IONPs). Two types of AAs, l-lysine (Lys) and l-phenylalanine (PhA), were selected to study their effects on loading capacity, release profile of CUR, biocompatibility, and anticancer activity. CUR-loaded AAs-modified IONPs (F@AAs@CUR NPs) were characterized by X-ray diffraction (XRD), thermogravimetric analysis (TGA), Fourier transform infrared spectroscopy (FTIR), vibrating sample magnetometer (VSM), and transmission electron microscopy (TEM) techniques. Next, the various kinetic equations were fitted to the release data of CUR from F@Lys@CUR NPs and F@PhA@CUR NPs. Additionally, hemolysis test and MTT assays on HFF-2 and HEK-293 cell lines were performed for determination of biocompatibility of AAs-coated IONPs. Finally, the anticancer activity of F@AAs@CUR NPs examined on MCF-7 breast cancer cell line. The results indicate that these nanocarriers are nontoxic and biocompatible and also F@AAs@CUR NPs are suitable carriers for delivery of curcumin and even other hydrophobic drugs. Also, the MRI training established the effectiveness of IONPs as contrast agent for the ...Continue Reading

References

Mar 21, 2006·BMC Complementary and Alternative Medicine·Christopher D LaoDean E Brenner
Jan 13, 2010·Chemical Communications : Chem Comm·Jin XieXiaoyuan Chen
Nov 3, 2010·International Journal of Pharmaceutics·Tae Hyung KimKang Choon Lee
Jul 1, 2011·Nanoscale·Morteza MahmoudiSophie Laurent
Feb 10, 2012·Chemical Society Reviews·Yue PanBing Xu
Oct 28, 2014·Artificial Cells, Nanomedicine, and Biotechnology·Eommolbanin EbrahimiSoodabeh Davaran
Sep 22, 2015·Chemical Society Reviews·Hamed AramiKannan M Krishnan
Mar 1, 2016·Artificial Cells, Nanomedicine, and Biotechnology·Hongying LiangParimala Nacharaju
Mar 10, 2016·Materials Science & Engineering. C, Materials for Biological Applications·E TakematsuN Matsushita
Apr 7, 2016·Artificial Cells, Nanomedicine, and Biotechnology·Saeid Shabestari KhiabaniSoodabeh Davaran
Sep 16, 2016·Artificial Cells, Nanomedicine, and Biotechnology·Seyed Mohsen AberoumandiSoodabeh Davaran
Jul 30, 2017·Artificial Cells, Nanomedicine, and Biotechnology·Lida AhmadkhaniMojtaba Abbasian
Mar 22, 2018·Drug Development and Industrial Pharmacy·Hamed NosratiManjili Hamidreza Kheiri
Apr 14, 2018·International Journal of Biological Macromolecules·Marziyeh SalehiabarHossein Danafar
Feb 14, 2014·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Miriam MartínJosé Luis González-Mora

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.